FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $685,000 | -3.0% | 11,708 | -1.7% | 0.02% | -9.1% |
| Q3 2021 | $706,000 | -31.7% | 11,915 | 0.0% | 0.02% | -26.7% |
| Q2 2021 | $1,034,000 | +123.3% | 11,915 | +112.4% | 0.03% | +114.3% |
| Q1 2021 | $463,000 | -13.8% | 5,610 | -5.1% | 0.01% | -17.6% |
| Q4 2020 | $537,000 | -38.8% | 5,910 | -92.4% | 0.02% | -34.6% |
| Q2 2018 | $877,000 | +12.0% | 77,304 | -3.7% | 0.03% | -3.7% |
| Q1 2018 | $783,000 | – | 80,247 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |